Nano drug (AgNPs capped with hydroxychloroquine): Synthesis, characterization, anti-covid-19 and healing the wound infected with S. aureus

Almost existing anti-viral drugs are only organic molecules that are able to circumvent the system the virus works with, which leaves it facing the immune system of our bodies and then kills it. Unfortunately, this type of pharmacological fight did not succeed in a way to overcome this virus, so it became necessary to think outside the box, to find a drug that would kill the virus or alter its protein structure. This research aims to prepare silver nanoparticle (AgNPs) by the green method depending on the reaction of the silver nitrate (safe for humans) with the phoenix dactylifera extract (safe for humans) and then coated with the hydroxychloroquine (HQ, known antiviral drug). This substance will fight the virus with different mechanisms (i) silver will carry the drug to cells easily, and then (ii) nano silver will perform a physical inhibition of the virus and thus reduce its susceptibility to binding to host cells. In addition, (iii) silver nanoparticle is much smaller than the size of the virus which qualifies it to cross into the virus and change the structure of RNA. Furthermore, (iv) it is possible for silver to interact with the amino and carboxylic ends in the virus proteins. The results of TCID50 shows that the prepared nano drug is able to reduce the viability of covid-19 to about 22% using 400 mg/ml of AgNPs/HQ. The resulted nanodrug was also used for healing the wound infected with S. aureus and the histological results revealed that all of the disease symptoms improved, with the epidermal layer multiplying quickly and the infected wounds healing quickly.